UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

Antimicrobial agents and chemotherapy, 2017-04, Vol.61 (4)

2017

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program

Antimicrobial agents and chemotherapy, 2017-12, Vol.61 (12)

2017

Link zum Volltext

Verfügbarkeit prüfen

Gepotidacin (GSK2140944) In Vitro Activity against Gram-Positive and Gram-Negative Bacteria

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species

Diagnostic microbiology and infectious disease, 2015-04, Vol.81 (4), p.259-263

2015

Link zum Volltext

Verfügbarkeit prüfen

Erratum for Pfaller et al., " In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014"

Antimicrobial agents and chemotherapy, 2018-02, Vol.62 (2)

2018

Link zum Volltext

Verfügbarkeit prüfen

Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021)

Journal of clinical microbiology, 2024-02, Vol.62 (2), p.e0114123

2024

Link zum Volltext

Verfügbarkeit prüfen

Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020)

Antimicrobial agents and chemotherapy, 2022-11, Vol.66 (11), p.e0102822-e0102822

2022

Link zum Volltext

Verfügbarkeit prüfen

Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values

Diagnostic microbiology and infectious disease, 2015-08, Vol.82 (4), p.303-313

2015

Link zum Volltext

Verfügbarkeit prüfen

Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014)

Diagnostic microbiology and infectious disease, 2018-02, Vol.90 (2), p.143-147

2018

Link zum Volltext

Verfügbarkeit prüfen

Activity of omadacycline tested against Enterobacteriaceae causing urinary tract infections from a global surveillance program (2014)

Diagnostic microbiology and infectious disease, 2018-06, Vol.91 (2), p.179-183

2018

Link zum Volltext

Verfügbarkeit prüfen

Telavancin Activity Against Gram-Positive Bacteria Isolated from Patients with Skin and Skin-Structure Infections

Journal of chemotherapy (Florence), 2010-10, Vol.22 (5), p.304-311

2010

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995

Antimicrobial agents and chemotherapy, 2001-06, Vol.45 (6), p.1721-1729

2001

Link zum Volltext

Verfügbarkeit prüfen

Neisseria meningitidis with decreased susceptibility to penicillin: Report from the SENTRY antimicrobial surveillance program, North America, 1998–99

Diagnostic microbiology and infectious disease, 2001-09, Vol.41 (1), p.83-88

2001

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and moraxella catarrhalis

Antimicrobial agents and chemotherapy, 2000-02, Vol.44 (2), p.447-449

2000

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii

Journal of chemotherapy (Florence), 2005-12, Vol.17 (6), p.622

2005

Link zum Volltext

Verfügbarkeit prüfen

A 1997–1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions

International journal of antimicrobial agents, 1999-10, Vol.13 (2), p.99-107

1999

Link zum Volltext

Verfügbarkeit prüfen

Molecular Characterization of the β-Lactamases from Clinical Isolates of Moraxella (Branhamella)catarrhalis Obtained from 24 U.S. Medical Centers during 1994–1995 and 1997–1998

Antimicrobial Agents and Chemotherapy, 2000-02, Vol.44 (2), p.444-446

2000

Link zum Volltext

Verfügbarkeit prüfen

Outbreak of Severe Pseudomonas aeruginosa Infections Caused by a Contaminated Drain in a Whirlpool Bathtub

Clinical infectious diseases, 2000-12, Vol.31 (6), p.1331-1337

2000

Link zum Volltext

Verfügbarkeit prüfen

Carbapenem Susceptibility Discords among Acinetobacter Isolates

Clinical infectious diseases, 2006-01, Vol.42 (1), p.158-158

2006

Link zum Volltext

Verfügbarkeit prüfen

Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp

Diagnostic microbiology and infectious disease, 2001-05, Vol.40 (1), p.45-49

2001

Link zum Volltext

Verfügbarkeit prüfen

Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere

American journal of obstetrics and gynecology, 2000-10, Vol.183 (4), p.859-862

2000

Link zum Volltext

Verfügbarkeit prüfen

Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008)

Diagnostic microbiology and infectious disease, 2009-12, Vol.65 (4), p.414-426

2009

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens

Journal of antimicrobial chemotherapy, 2013-03, Vol.68 (3), p.636-639

2013

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: Report of year five (2003)

Diagnostic microbiology and infectious disease, 2004-08, Vol.49 (4), p.273-281

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(94)
Japanisch
(11)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(74)
Humans
(63)
Microbiology
(55)
Biological And Medical Sciences
(44)
Infectious Diseases
(42)
Medical Sciences
(40)
Microbial Sensitivity Tests
(40)
Anti-Bacterial Agents - Pharmacology
(34)
Pharmacology & Pharmacy
(24)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(23)
Pharmacology. Drug Treatments
(23)
Fundamental And Applied Biological Sciences. Psychology
(20)
Antibacterial Agents
(18)
Male
(17)
Female
(15)
Gram-Negative Bacteria - Drug Effects
(14)
Bacteriology
(13)
United States
(13)
Adult
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program

Gepotidacin (GSK2140944) In Vitro Activity against Gram-Positive and Gram-Negative Bacteria

In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae

In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species

Erratum for Pfaller et al., " In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014"

Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021)

Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020)

Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values

Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014)

Activity of omadacycline tested against Enterobacteriaceae causing urinary tract infections from a global surveillance program (2014)

Telavancin Activity Against Gram-Positive Bacteria Isolated from Patients with Skin and Skin-Structure Infections

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995

Neisseria meningitidis with decreased susceptibility to penicillin: Report from the SENTRY antimicrobial surveillance program, North America, 1998–99

In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and moraxella catarrhalis

In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii

A 1997–1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions

Molecular Characterization of the β-Lactamases from Clinical Isolates of Moraxella (Branhamella)catarrhalis Obtained from 24 U.S. Medical Centers during 1994–1995 and 1997–1998

Outbreak of Severe Pseudomonas aeruginosa Infections Caused by a Contaminated Drain in a Whirlpool Bathtub

Carbapenem Susceptibility Discords among Acinetobacter Isolates

Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp

Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere

Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008)

Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens

Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: Report of year five (2003)

Suchergebnisse filtern